We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Aptose to Present at the RBC Capital Markets 2015 Global Healthcare Conference
News

Aptose to Present at the RBC Capital Markets 2015 Global Healthcare Conference

Aptose to Present at the RBC Capital Markets 2015 Global Healthcare Conference
News

Aptose to Present at the RBC Capital Markets 2015 Global Healthcare Conference

Read time:
 

Aptose Biosciences Inc. has announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will present at the upcoming RBC Capital Markets 2015 Global Healthcare Conference on Tuesday, February 24th at 1:35 p.m. ET at the Kennedy 1 Room at the New York Palace Hotel in New York City.

Dr. Rice will provide a corporate overview of the Company's recent activities and strategic direction including plans to develop Aptose's lead clinical agent, APTO-253 for acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and other hematologic malignancies.

A live audio webcast of the Aptose presentation will be accessible by visiting: http://www.veracast.com/webcasts/rbc/healthcare2015/84110376508.cfm.

Advertisement